Improved patient access and outcomes with the integration of an eConsult program (teledermatology) within a large academic medical center - 03/03/20
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Background |
Insurance, racial, and socioeconomic health disparities continue to pose significant challenges for access to dermatologic care. Studies applying teledermatology to increase access to underinsured individuals and ethnic minorities are limited.
Objective |
To determine how the implementation of a teledermatology program affects access to health care and patient outcomes.
Methods |
A cross-sectional evaluation was performed of all ambulatory dermatology referrals and electronic dermatology consultations (eConsults) at Ohio State University within a 25-month period.
Results |
Compared with ambulatory referrals, eConsults served more nonwhite patients (612 of 1698 [36.0%] vs 4040 of 16,073 [25.1%]; P < .001) and more Medicaid enrollees (459 of 1698 patients [27.0%] vs 3266 of 16,073 [20.3%]; P < .001). In addition, ambulatory referral patients were significantly less likely to attend their scheduled appointment compared with eConsult patients, as either “no-shows” (246 of 2526 [9.7%] vs 3 of 62 [4.8%]) or cancellations (742 of 2526 [29.4%] vs 8 of 62 [12.9%]; P = .003). There were fewer median days to extirpation for eConsult patients compared with ambulatory referral patients (interquartile range; 80.7 ± 79.8 vs 116.9 ± 86.6 days; P = .004).
Conclusion |
Integrating dermatologic care through a telemedicine system can result in improved access for underserved patients through improved efficiency outcomes.
Le texte complet de cet article est disponible en PDF.Key words : e-Consult, electronic consultation, health disparities, socioeconomic disparities, teledermatology, telemedicine
Plan
Funding sources: This study was funded by the Upper Payment Limit Awards granted through the Ohio Department of Medicaid to Drs Wexler and Kaffenberger. |
|
Conflicts of interest: None disclosed. |
|
IRB approval status: This study used quality control data and was exempt from Institutional Review Board review. |
|
Reprints not available from the authors. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?